AR226-2283 M ark H R u ssell 05/06/2002 11:20 AM To: Catherine A Barton/AE/DuPont@ DuPont cc: Subject: M odeling so il concentrations Cathy, I tried calling you but you w eren't in.
refid# n9yq8LYvKM4vZGGK1jejjx5XX1 page
AR226-2325 ^ John W M ilro yJII 04/03/2003 05:41 PM To: co: Subject: Catherine A Barton/AE/DuPont@ DuPont Stephen R Hastings/DDE/DuPont@ DuPont, Ann K Masse/HO/DuPont@ DuPont, Charles J Zarzecki/AE/DuPont@ DuPont Re: Data fo r a ir dispersion modeling D This is the data for DuPont Dow, building 1163, C 8 release to the am osphere.
refid# yp4v34KmBvYLQm9QjMnanqan21 page
DuPont Engineering AR226-2575 DuPont Engineering Barley M il P la za -B ld g . 27 Lancaster Pike &Rte, 14!
refid# aELQq7RqJb8M7RM9QKyOw9dN1 page
AR226-3168 DuPont-4292 TRADE SECRET Study Title H-24267: Two-Week Inhalation Toxicity Study in Male Rats Laboratory Project ID: DuPont-4292 AUTHOR: David P.
refid# 3ejBre0x2zzX2V3Lg8mMLXEzy181 pages
t i u ; t i n ' t it *i r i tt** ' M V' Mt' 't '< l\:>ii * 1 \ " June to ,2006 x *|3f 1 ,i*- I f 1 Document Control Office Docket AR-226 EPA Hast Building, Room 6428 1201 Constitution Ave., NAV, Washington, DC 20460 Phone: 202-564-8030 Attention: OPPT Docket No.
refid# 30LoXmaEkOVexkjgg700V9bx2 pages
P-1 ENVIRONMENT CANADA AND HEALTH CANADA CONSULTATIONS ON THE PROPOSED ACTION PLAN FOR PERFLUOROCARBOXYLIC ACIDS AND PRECURSORS REPORT OF CONSULTATION MEETING Ottawa, Ontario, Canada February 6 and 7,2006 P-2 Table of Contents INTRODUCTION............................................................................................................... 2 WELCOME/OBJECTIVES..............................................................................................3 PART 1 THE SCIENTIFIC CONTEXT................................................................... 4 PFCAs and Precursors: Simplified Terminology/Sources and Fate...............................4 Environmental Fate of Fluorotelomer Based Substances...............................................5 External Review and Science Update............................................................................. 8 PART 2 THE REGULATORY CONTEXT.............................................................. 8 Assessment and Management of Substances.................................................................. 9 PART 3 PROPOSALS ON PFCAs AND PRECURSORS...................................... 9 Overview o f Proposed Action Plan................................................................................. 9 Proposed Action Plan: New Substances....................................................................... 11 FEEDBACK ON PROPOSED ACTIONS FOR NEW SUBSTANCES.............12 Process for preparing a Regulatory Impact Analysis Statement.................................... 13 Proposed Action Plan: Existing Substances...................................................................14 FEEDBACK ON PROPOSED ACTIONS FOR EXISTING SUBSTANCES .. 14 Proposed Action Plan: Research and International Cooperation..................................16 CLOSING COMMENTS AND NEXT STEPS............................................................. 18 APPENDIX A: Consultation Agenda APPENDIX B: List of Participants Environment Canada Health Canada - PFCAs and Precursors: Action Plan Consultations - Report page 1 P-3 INTRODUCTION In 2004, the New Substances Program of Environment Canada and Health Canada assessed four new substances which are considered sources of perfluorinated carboxylic acids (PFCAs).
refid# X7G6G7JRLkw3pa9n9q16ydpYR27 pages
P-1 COMPANY SANITIZED - Does not contain TSCA Confidential Business Information (CBI) DAUUN AZza _ 3730 fi o>2 <> DAIKIN AMERICA, INC. 905 State Docks Road (35601) P.O.
refid# QgbpqOx5Qw47NbrYLa7xLbbg42 pages
Betty Boros-Russo - PFOA From: To: Date: Subject: <Laura.Vancho@amwater.com> <Betty.Boros-Russo@dep.state.nj.us> Wed, Dec 26, 2007 10:23 AM PFOA Hope you are enjoying the holidays.
refid# gD4vZD1QRLDqX13Xkq1KLOrMJ5 pages
CONFIDENTIAL, SUBJECT TO PROTECTIVE ORDER IN ROWE/COLES NJAWWestem Sample Date System Location Sample Type PFOA/PFOS Monitoring Prep Date Analysis Date Surrogate Recovery <%> RESULT (U0/ PFOA PFOS 2006-2007 Comments 06/23/06 03/13/07 04/17/07 03/13/07 03/13/07 03/13/07 07/06/06 03/13/07 04/17/07 Western DRRWTP Effluent Western DRRWTP Effluent Western DRRWTP Effluent Wstern DRRWTP Filtered Western DRRWTP Settled Western DRRWTP Inlet Western DRRWTP Intake Western DRRWTP Intake Western DRRWTP Intake SW.
refid# QJv2RbbLBevEeyM5KkzVD4Y0k8 pages
SEVERN TRENT LABORATORIES ANALYTICAL REPORT JOB NUMBER: 239579 Prepared For: Weston Solutions, Inc. 1400 Weston Way Building 5-2 West Chester, PA 19380-1499 Project: Confidential Decatur - FC Investigation Attention: Sue Stefanosky Date: 09/09/2005 Signature Name: Richard C.
refid# QM6EVvgpjZ4KVomYBKDeQmD618 pages
>*224-/SO P rsn 8ema/d - on 10/04/2001 08 26 AM cc SvOiect rhjrru^jtPv'fcncorp com swashburn@envtrencorD com M Am 8'<H*v.'
refid# 5LBn0ZwnDY7Rz0qwG6KbqLnb41 page
3M GGeenneerraall OOfffificcees.s 3M Center 3M Center Spo MN sick1000 St.
refid# baxV3dn4Y1x1eqpR5NXBLm50Z8 pages
TTTRATIYT MMaarrkkA.
refid# 5kGdrD6bRanG7aQZ4z25aJYwe1 page
AR226_ 1057 ft. sERoor-15057 sw @UPIND3 sanuary 17,2002 aor Eros 5 wpele DRArtootceofnumtmieo8ofnn4:t2P88oP(relo)ceCeonsosrPidrniognvaCetemonirtoenr (Mail Code and Toxics 7407M).
refid# 9JperGBV8MrMKgQd9GK7LorE71 page
foes R226 -- 359 SRPT T7001 MIN 315/022356 PERFLUOROOCTANESULFONYL FLUORIDE (POSF) T-Tebl> IN VITRO MAMMALIAN CHROMOSOME ABERRATION TEST IN HUMAN LYMPHOCYTES Sponsor 33MMCCeanrtpeorrt Toxicology SBiupilding T0250 UMsNa551333220 Page t0r3t ResearchLaboratory WHouomilnlgydRoenaLidfe Sciences Ld AHocnoinnbguiroyn PCeaamstradkgesire ENGLAND Reporsued 22 Osober 2002 001542 CONTENTS MIN3157022356 Page COMPLIANCEWITHGOODLABORATORY PRACTICESTANDARDS... 4 QUALITYASSURANCESTATEMENT. ccm eS RESPONSIBLE PERSONNEL... 6 INTRODUCTION sss 8 EXPERIMENTALPROCEDURE...
refid# jg18Gwr11BdJkOax2k2abGpZR28 pages